Page 11 - The Wistar Institute

Oncology & Cancer

Mechanism of an effective MEK inhibitor identified

Understanding the effects of certain targeted therapies on antitumor immunity is necessary to design combined interventions for more effective cancer treatment. In the past, data have shown that trametinib, an FDA-approved ...

Oncology & Cancer

Estrogen signaling impacted immune response in cancer

While the role of estrogen signaling in tumor development is well understood in breast and ovarian cancer, its role in anti-tumor immunity has not been extensively studied. However, new research from The Wistar Institute ...

Genetics

Two key proteins preserve vital genetic information

Cancer is often driven by various genetic mutations that are acquired through changes to a person's DNA over time. These alterations can occur at the chromosome level if the proteins are not properly organized and segregated ...

Oncology & Cancer

Low oxygen, high risk: How tumors adapt to become more aggressive

One of the many reasons tumors are so difficult to treat is that they are able to adapt whenever they are exposed to unfavorable conditions. Hypoxia, or a lack of oxygen, is one example of a phenomenon that should weaken ...

Immunology

Scientists identify marker for myeloid-derived suppressor cells

Myeloid-derived suppressor cells (MDSCs) are a population of immune cells that have been implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy. Polymorphonuclear ...

Oncology & Cancer

T-cells can be directed to treat a variety of ovarian cancers

With only incremental improvements in ovarian cancer survival over the last 40 years, there is a clear need for new treatment options with long-lasting results. Many researchers have turned toward the development of immunotherapies ...

Oncology & Cancer

Aging impacts therapeutic response of melanoma cells

Cancer risk increases with one's age as accumulated damage to our cells and chronic inflammation occur over time. Now, an international team of scientists led by The Wistar Institute have shown that aged tumor cells in melanoma ...

page 11 from 15